RI A
HI
ITA
LIAN
A
AT
À
ET
SO CI
II Forum Internazionale
Changes in Psychiatry
DI P
S IC
15-16 Maggio 2014
Roma, Italia
III International Conference
on Novel Psychoactive Substances (NPS):
Focus 1: Update in Psychopharmacology,
Comorbidity Treatment, Pharmacological Interactions,
Side effects management
Focus 2: “NPS and New Behavioural Addictions”
Scientific committee:
• Dr Dario Carrus, Sapienza University of Rome
• Dr Ornella Corazza, University of Hertfordshire
• Prof Fabrizio Schifano, University of
Hertfordshire
• Paul Griffiths, EMCDDA Scientific Director
• Dr Roumen Sedefov, Head of unit, Supply
reduction and new trends, EMCDDA
• Dr Ana Gallegos, Head of sector, Action on new
drugs, EMCDDA
• Dr Giovanni Martinotti, University of ChietiPescara
• Dr Alessandro Vento, Guglielmo Marconi
University
• Prof Paolo Girardi, Sapienza University of Rome
• Prof Giuseppe Bersani, Sapienza University of
Rome
• Prof Massimo di Giannantonio, University of
Chieti-Pescara
• Prof Luigi Janiri, Catholic University of Rome
• Dr Giuseppe Ducci, San Filippo Neri Hospital Rome
Abstract and Registration
Administrators:
• Dr Rita Santacroce, University of Hertfordshire &
Chieti-Pescara
• Dr Eduardo Cinosi, University of Hertfordshire &
Chieti-Pescara
Naomi Austin, University of Hertfordshire
Online streaming:
• Billy Liu, University of Hertfordshire
• Kieran O’Shea, University of Hertfordshire
• Cheri Hunter, University of Hertfordshire
Conference website:
www.novelpsychoactivesubstances.eu
Venue
Domus Pacis Torre Rossa,
Via di Torre Rossa, 94, 00165
Rome, Italy
www.domuspacistorrerossapark.it/en/home.html
Rationale
The recent emergence of novel (or new) psychoactive substances (NPS), combined with the ability of the
Internet to disseminate information quickly, have raised a number of challenges in the fields of drug policies,
substance use research and public health across the EU and internationally. Despite increasing amount of
attention being given to this area, these new emerging products, often unregulated and sold online as ‘legal’
and ‘safer’ alternatives to traditional illicit drugs, are rarely mentioned in scientific literature, and there is
limited information available on their nature and potential risks. The EU early‐warning system, operated
by the EMCDDA, currently monitors over 300 new drugs. These include derivatives of phenethylamines,
tryptamines, piperazines and cathinones, as well as synthetic cannabinoids and a small number of herbal
substances that can produce psychoactive effects. Such a phenomenon highlights the importance of multinational and multi-disciplinary collaboration in order to enhance knowledge and improve the quality of
information sharing and good practices at a global level.
Objectives
The main objectives of this conference are:
• sharing accurate, evidence-based information on NPS and latest trends of misuse;
• improving understanding of treatment and management approaches for patients with levels of clinical and/
or behavioural toxicity associated with NPS use;
• assessing psychiatric consequences of NPS use and related behavioural addictions;
• developing innovative prevention measures especially for vulnerable individuals;
• raising awareness and contributing to the development of effective prevention messages;
• exploring socio-cultural factors underlying risky behaviours;
• contributing to the development of an international platform and other technological solutions for rapid
information sharing;
• networking and providing the opportunity to meet renowned experts in the field
Faculty
Prof. David M. Benjamin
Dr Gilberto Di Petta
Prof. Owen Bowden-Jones
Dr Giuseppe Ducci
Psichiatra -Professor Tufts Medical School in Boston - Adjunct
Associate Professor at Northeastern University Northeastern
University Boston, USA
Psichiatra - Consultant in Addiction Psychiatry and Honorary
Senior Lecturer at Imperial College - Division of Brain Science. Chair of the Faculty of Addictions at the Royal College of
Psychiatrists Imperial College of London,London, UK
Dr Dario Carrus
Psichiatra - Dirigente Psichiatra, CSM Montefiascone, AUSL
VT - Sapienza University of Rome Sapienza University of Rome
Roma, Italia
Dr Ornella Corazza
Antropologa - Academic Research Lead & Principal Lecturer in
Mental Health and Psychiatric Practice - Department of Postgraduate Medicine, School of Life and Medical Sciences University
of Hertfordshire UK
Prof. Sergio De Filippis
Psichiatra - Direttore Sanitario Casa di cura Neuropsichiatrica
Villa Von Siebenthal Villa von Siebenthal Roma, Italia
Prof Massimo di Giannantonio
Psichiatra - Docente Università degli Studi di Chieti, Facoltà di
Psicologia, Dipartimento di Scienze biomediche, University of
Chieti - Pescara Chieti - Pescara, Italia
Psichiatra - Responsabile U.O.S.D. Doppia Diagnosi, Dipartimento Dipendenze ASL Napoli 2 Nord ASL Napoli 2 Nord Napoli,
Italia
Psichiatra - Direttore UOC SPDC San Filippo Neri, Roma San
Filippo Neri Hospital, Roma, Italia
Prof. Andrea Fagiolini
Psichiatra - Professore associato Università di Siena, Direttore
dipartimento interaziendale di salute mentale Università di
Siena, Siena, Italia
Dr Ana Gallegos
Chimico - European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Head of sector, Action on new drugs, EMCDDA,
CEE
Prof Paolo Girardi
Psichiatra - Professore Ordinario di Psichiatria, Direttore UOC
di Psichiatria, Azienda Ospedaliera Sant’Andrea, Facoltà di
Medicina e Psicologia, La Sapienza Università di Roma Sapienza,
Roma, Italia
Mr Paul Griffiths
Epidemiologo - European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA) EMCDDA Scientific Director, CEE
Prof Luigi Janiri
Neurologo - Professore associato Facoltà di MEDICINA E CHIRURGIA Sede di Roma Psichiatria e Psicologia Università La
Cattolica di Roma, Roma, Italia
Dr Sabrina Levissianos
Economista - Associate Drug Control Officer at the United
Nations Office on Drugs and Crime (UNODC) - Global Synthetics
Monitoring: Analyses, Reporting and Trends (SMART) Programme UNODC CEE
Dr Giovanni Martinotti
Prof Fabrizio Schifano
Psichiatra - Professore Ordinario di Farmacologia Clinica e Terapia, Faculty of Health and Human Sciences, School of Pharmacy,
University of Hertfordshire (UK), Primario Psichiatra (Dipendenze), Servizio Tossicodipendenze e Alcolismo, Hertfordshire
(UK) University of Hertfordshire Hartfield, UK
Dr Roumen Sedefov
Psichiatra - European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA) Head of unit, Supply reduction and new
trends, EMCDDA CEE
Psichiatra - ricercatore presso Dipartimento di Neuroscienze
Imaging, Università degli studi di Chieti, “G. D’Annunzio” University of Chieti-Pescara Chieti, Pescara, Italia
Mr Harry Shapiro
Sir Robin Murray
Dr Alessandro Vento
Prof Andy Parrott
Prof Matthew Young
Psichiatra - Professor of Psychiatric Research at the Institute
of Psychiatry, King’s College London Kings College of London,
London, UK
Psichiatra - Professor in Department of Psychology, Swansea
University UK, is an international authority on the human
psychobiology of MDMA or Ecstasy University of Swansea,
Swansea, UK
Giornalista - Head of Publishing and Director of Communications Drugscope Cardiff, UK
Psichiatra - Dirigente Psichiatra, ASL RMC, Dottorato di ricerca
Università “La Sapienza” Roma. Guglielmo Marconi University
Roma, Italia
Psicologo - Senior Research and Policy Analyst at the Canadian
Centre on Substance Abuse (CCSA) - Adjunct Research Professor
of Psychology at Carleton University in Ottawa CCSA Ottawa,
Canada
Thursday, May 15th
Focus 1
Advanced course of
psychopharmacology Focus on
Bipolar, Schizophrenia, Depression,
Comorbid Drug Abuse and Mental
Illness. Polypharmacy, polypharmacy
interaction and side effect managment
Welcome
Perspective.
Gilberto Di Petta
Pausa
11.00
Sponsored by Otsuka
Introduction/Chair
Paolo Girardi
Paolo Girardi, Dario Carrus, Ornella Corazza
Chairs Fabrizio Schifano, Giuseppe Ducci
9.00 Introduction to the world of dual
diagnosis, between exogenous and
endogenous psychosis
Paolo Girardi, Italy
9.30
The art and science of combining
medications
Andrea Fagiolini
10.00Emerging Novel Psychoactive Substances
Related Disorders: The Psychopathological
Simposio: The management of complex
patient. Between psychosis, affective
disorders and addiction
Addiction and induced phenomena: which
pharmacological strategy?
Giovanni Martinotti
12.15
Questions time: The management of
complex patient.. Between psychosis,
affective disorders and addiction.
Discussant: Fabrizio Schifano, Sergio De
Filippis, Alessandro Vento
Thursday 15th May 2014
Third International Conference on Novel Psychoactive Substances
Location: Domus Pacis Torre Rossa
13:00
Registration
Chairs: Paolo Girardi, Dario Carrus, Roumen
Sedefov, Ana Gallegos, Ornella Corazza,
Fabrizio Schifano
14:00 Welcome – Opening
14:10 The past, present and future of new drugs
14:30 The UNODC Early Warning Advisory
on Novel Psychoactive Substances: new
trends
Paul Griffiths & Roumen Sedefov, EMCDDA
Sabrina Levissianos, UNODC
14:50 Use of Novel Psychoactive Substances
and the risk of psychopathological
disturbances
Fabrizio Schifano, United Kingdom
15:10
Facing the challenge: Internet monitoring
and innovative prevention models
Ornella Corazza, United Kingdom
15:30
Using media to monitor the global spread
of Novel Psychoactive Substances
Matthew Young, Canada
15:50
Educating young people: encouraging
appropriate tv programs on drugs
Massimo di Giannantonio, Italy
16:10 New drugs, old stories: NPS, the media and
responsible communications
Harry Shapiro, United Kingdom
16:30
Break – Networking and Poster session
Thursday 15th May 2014
PARALLEL SESSIONS
16:45
17:45
Parallel Session I
Promoting effective Media and
Knowledge Exchange
Chairs: Karine Diedrich, Massimo di
Giannantonio, Harry Shapiro, Matthew Young,
Sabrina Levissianos
Vincent Benso and Leo Meignen, France
18:00
18:15
Working with the media: challenges and
solutions
A national agency response to new
psychoactive substances
Psyclone or Psy-clones? Caught in the
middle of the drug “Clone Wars”
Rita Santacroce, Italy
17:30
Dazed and confused: a brief overview of
novel psychoactive substances as new
challenge for healthcare professionals
Pierluigi Simonato, United Kingdom
An epidemiological study on Novel
Psychoactive Substances and impact on
mental health
Antonio Metastasio, United Kingdom
Parallel Session II
Clinics and Therapeutics
16:45 The online availability of prescription
drugs: the interesting case of codeine
Vicki Craik, United Kingdom
17:15
Novel Psychoactive Substances: New
Measures for Harm Reduction
Levente Mòrò, Finland
Stefano Marroni, Italy
17:00
Novel Psychoactive Substances and harm
reduction : the peer to peer strategies
Chairs: Paolo Girardi, Giuseppe Valeriani, Oscar
D’Agnone, Giuseppe Ducci, Luigi Janiri, Kostas
Agath
Paolo Deluca, United Kingdom
Thursday 15th May 2014
17:00
How Sinsemilla (skunk) use has reshaped
the association between cannabis and
psychosis
Marta Di Forti, United Kingdom
17:15
17:30
17:45
(New) Glocal Syndemics: the ‘M-cat’ tale
Duccio Papanti, Italy
Emergence of illicit methadone injection
among people who inject drugs in St.
Petersburg, Russia
Robert Heimer, USA
Neurocognitive impairment, structural
brain alterations and psychopathology in
chronic cannabis users
Giuseppe Bersani, Italy
18:00
Drugs and alcohol: spotlight on substance
misuse training
Daniela Collins, United Kingdom
18:15
Social Learning Theory and initiation into
Salvia divinorum use
Brian Kelly, USA
18:30
Closure
Friday 16th May 2014
Location: Domus Pacis Torre Rossa
9:45 11:30 Giovanni Martinotti, Italy
Plenary Opening
Chairs: Sabrina Levissianos, Roumen Sedefov,
Paolo Girardi, Massimo Biondi, Alberto
Siracusano
10:00 The European Early Warning System
10:20 Prohibited substances in sports: emphasis
on counterfeit and illegal drugs of abuse
11:50 Break - Networking and Poster Session
12:10 From club to clinic. What every clinician
needs to know about Novel Psychoactive
Substances harms and treatment
Owen Bowden-Jones, United Kingdom
Ana Gallegos EMCDDA
12:30
Irene Mazzoni, World Anti-Doping Agency
10:40 Establishing the pattern of acute toxicity
associated with novel psychoactive
substances
Cannabis, ‘Skunk’ and ‘Spice’: implications
for mental health?
Robin Murray, United Kingdom
Central Nervous System stimulant drugs:
why they are damaging to recreational
users
Andy Parrott, United Kingdom
12:50
Designer Drugs, Synthetic Cannabinoids
and the US Federal Analog Ac
David M. Benjamin, USA
Paul Dargan, United Kingdom
11:00
Novel Psychoactive Substances: a
comparison among psychosis
13:10
Lunch – Poster Session
PARALLEL SESSIONS
13:45
Parallel Session I
Pharmacology and Toxicology
Chairs: Andy Parrott, Jane Maxwell, Giuseppe
Bersani, Gordon R. Morse, Pierluigi Simonato,
Ruri Kikura-Hanajiri
Perspectives on the rise and fall of
psychoactive drugs: generational
forgetting, risk, availability, and
substitution of drugs
14:45
Is it putty or is it MSG?
15:00
Behavioral Pharmacology of Newer
Synthetic Drugs – The United States
15:15
Studies on binding affinities of newly
emerging synthetic cannabinoids at the
cannabinoid CB1 and CB2 receptors
15:30
15:45
WEDINOS: initial findings on the who, where
and what of now psychoactive substance use
16:00
Changes in electroencephalogram power
spectra and locomotor behaviour in rat
exposed to synthetic cannabinoids
16:15
Nahoko Uchiyama, Japan
The analysis of new psychoactive
substances - Five years of experiences
Using biomarkers in wastewater to
monitor community drug use
Jose Antonio Baz Lomba, Norway
Novel Psychoactive Substances as
adulterants of controlled drugs
Mireia Ventura, Spain
Dean Acreman, United Kingdom
14:30
Pharmacokinetics and pharmacodynamics
of mephedrone in humans
Bogumiła Byrska, Poland
Ruri Kikura-Hanajiri, Japan
14:15
Thomas Penders and Jonathan Lee, USA
Magi Farré, Spain
Jane Maxwell, USA
14:00
Ian Blagbrough, United Kingdom
Patterns of Toxicity and potential for
dependance associated with Camfetamine
misuse
Eduardo Cinosi, Italy
Friday 16th May 2014
13:45
Parallel Session II
15:00
New Substances, New Trends,
New Solutions
Ursula Blaszko, United Kingdom
Chairs: Paul Griffiths, Francesco Saverio
Bersani, Karine Diedrich, Matthew Young, Rita
Santacroce
15:15
Preventing NPS from Reaching Consumer
Markets
15:30
Alcohol and risky behaviours: binge
drinking and polyabuse
Luigi Janiri, Italy
14:15
Preliminary results on recreational NPS
misuse in a young general population sample
Alessandro Vento, Italy
14:30 The importance of NPS in online drug
markets: data from Silk Road 2.0
Fernando Caudevilla, Spain
14:45
The Body Brown: a single case study on
Melanotan
Rebekah Brennan, Ireland
Changing patterns of drug use in Georgiaa case of Krokodil
David Otiashvili, Georgia
Matthew Nice, International Narcotics Control
Board
14:00
Highs and lows: exploratory study of “legal
high” use, experiences and expectancies
Breaking worse: The emergence of
krokodil (desomorphine) and excessive
injuries among people who inject drugs in
Eurasia
Jean-Paul Grund, The Netherlands
15:45
The evolution and characteristics of UK
deaths involving GHB and its analogues
John Corkery, United Kingdom
16:00
Legal highs – do you want to be my guinea
pig?
Luc Both, Luxembourg
16:15
The ‘drug policy ratchet’: why do sanctions
for NPS typically only go up?
Alex Stevens
16:30
Closure
Informazioni generali
Sede congressuale
DOMUS PACIS
Torre Rossa Park
Via di Torrerossa, 94 - 00165 Rome
Tel. 06 660071 - Fax 06 66007816
[email protected]
www.domuspacistorrerossapark.it
COME ARRIVARE alla sede congressuale
Dalla stazione Termini
Metro linea A direzione “Battistini” scendere alla
fermata “Cornelia” Bus 889 ogni 20 min direzione
“Mazzacurati” scendere alla fermata Domus Pacis.
(1300 metri)
Dall’aeroporto di Fiumicino Leonardo Da Vinci
Raggiungere la stazione Termini con il treno
“Leonardo Express” ogni 30 min dalla stazioni treni
del terminal. Oppure con i bus Terravision o Schaffini
seguendo le indicazioni per stazione Termini.
Dal Grande Raccordo Anulare
Uscita n 1 del GRA direzione centro “Aurelio-Città del
Vaticano” dopo 800 mt direzione Aurelia Antica per
700mt bivio con via di Torre Rossa. td>
http://www.domuspacistorrerossapark.it/it/
posizione.html#sthash.G5FUMYLV.dpuf
DESTINATARI del Simposio
e accreditamento ECM
Il corso è a numero chiuso e prevede un massimo di
150 partecipanti. È rivolto a Medici chirurghi (150)
specializzati in Psichiatria, Neurologia, Cardiologia,
Endocrinologia.
Le discipline non indicate non sono state accreditate,
gli specializzati di tali discipline non avranno i crediti
formativi anche se consegneranno regolarmente il
questionario ECM.
Per ottenere l’attribuzione dei crediti formativi è
necessario:
-compilare e restituire l’intera documentazione che
sarà consegnata durante il corso
-superare il test di valutazione dell’apprendimento
-partecipare nella misura del 90% ai lavori scientifici
-registrare la propria presenza firmando gli appositi
moduli
NON VERRANNO ACCETTATI I DOCUMENTI
CONSEGNATI DA ALTRI DIVERSI DAL
PARTECIPANTE STESSO
Informazioni generali
ISCRIZIONE al CORSO
Le iscrizioni sono a numero chiuso e riservate a 150
medici chirurghi. Si prega di inviare l’iscrizione alla
Segreteria Organizzativa MOMEDA EVENTI s.r.l.
([email protected] - fax 051 5876848) entro
il giorno 2 Maggio 2014, solo ed esclusivamente se
seguite da regolare pagamento della quota.
Qualora le domande eccedessero il numero di posti
disponibili, l’ammissione seguirà l’ordine di arrivo
delle schede.
Per gli enti pubblici fa fede la lettera di impegno. Per
l’esenzione dell’IVA da parte degli Enti è necessario
allegare la dichiarazione di esenzione. SOLO GLI ENTI
PUBBLICI POSSONO ESSERE ESENTI IVA
Non saranno accettate iscrizioni telefoniche.
Conferma di iscrizione
Entro 15 giorni dalla ricezione del pagamento sarà
inviata via e-mail una conferma di iscrizione
CANCELLAZIONI
LA QUOTA DI ISCRIZIONE VERRÀ RESTITUITA per
disdette entro il 2 maggio 2014 con una trattenuta di
€ 30 (costi di gestione pratica). Per disdette dopo tale
data non è previsto alcun rimborso.
I rimborsi saranno comunque effettuati dopo la data di
fine del corso. I “No shows“ non sono rimborsabili.
É possibile effettuare cambi di nominativi ma saranno
accettati solo per iscritto.
QUOTE di ISCRIZIONE:
Figura professionale
Quota di
iscrizione
Medico chirurgo
250,00 € + iva 22%
Medico in formazione - Studenti
150,00 € + iva 22%
Cena sociale
60,00 € + iva 22%
METODI di PAGAMENTO
Assegno bancario o circolare non trasferibile
intestato a Momeda Eventi S.r.l. da spedire in busta
chiusa a: Momeda Eventi S.r.l. - Via San Felice, 38 – I 40122 Bologna
Bonifico bancario
al netto di spese bancarie a favore di Momeda Eventi
S.r.l., sul conto corrente con IBAN IT 64 L 06385 02412
100000003977 – BIC IBSPIT2B CARISBO AGENZIA
5012 SAN FELICE - VIA RIVA RENO, 10 BOLOGNA
Causale del versamento “Changes in Psychiatry 2014nome ISCRITTO”
In contanti o assegno in sede congressuale
General information
CONFERENCE VENUE
DOMUS PACIS
Torre Rossa Park
Via di Torrerossa, 94 - 00165 Rome
Tel. +39 06 660071 - Fax +39 06 66007816
[email protected]
www.domuspacistorrerossapark.it
GETTING to the conference venue
From Termini station
• Take Metro line A (direction Battistini) to the
“Cornelia” stop. From here bus 889 (direction
“Mazzacurati”) departs every 20 minutes. It is 1.3km
to the “Domus Pacis” stop.
From Fiumicino airport “Leonardo Da Vinci”
• Take either the Leonardo Express train or the
Terravision or Schiaffini buses to Termini station.
From Termini take Metro line A (direction Battistini)
to the “Cornelia” stop. From here bus 889 (direction
“Mazzacurati”) departs every 20 minutes. It is 1.3km
to the “Domus Pacis” stop.
From “Grande Raccordo Anulare”
Take exit n°1 of the G.R.A. and follow signs for Aurelio Città del Vaticano. After 800m follow signs for Aurelia
Antica. After 700m turn left onto via di Torre Rossa.
http://www.domuspacistorrerossapark.it/en/
posizione.html
REGISTRATION
Registrations are reserved to 200 medical doctors.
Please complete and submit this form to MOMEDA
EVENTI s.r.l. ([email protected] - fax +39 051
5876848).
Deadline for registrations is May 2nd 2014. Payment
must be made together with the registration.
We will send a registration confirmation within 15
days after receiving your payment.
CANCELLATION POLICY
If you have to cancel you registration, notification
in writing should be sent to MOMEDA EVENTI s.r.l.
([email protected] - fax 051 5876848) before
May 2nd, 2014. A refund will be given for cancellation
received before May 2nd, 2014 with a recoupment of
30 €. Refund will be made after the conference.
Cancellation received after May 2nd, 2014 will not be
eligibile for a refund.
If you need to make a change please write to MOMEDA
EVENTI s.r.l. ([email protected] - fax 051
5876848)
General information
REGISTRATION FEES
Registration fee
Standard fee
250,00 €
Students
150,00 €
Social dinner
60,00 €
Online Streaming
80,00 €
METHODS OF PAYMENT
By cheque
made payable to Momeda Eventi S.r.l..
Please send to: Momeda Eventi S.r.l.
Via San Felice, 38 – I - 40122 Bologna
By wire transfer
Name of payee: Momeda Eventi S.r.l.Name of the
Bank to wich the payment should be sent: CARISBO
AGENZIA 5012 SAN FELICE Address of the bank: VIA
RIVA RENO, 10 BOLOGNA (ITALY)Bank IBAN: IT 64
L 06385 02412 100000003977 – BIC IBSPIT2B Your
name (that should appear on transfer): /NPS 2014
By credit card
please refer to
http://www.novelpsychoactivesubstances.org:
REGISTRATION
By cash on site payment